267
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Clinical efficacy of bromocriptine and the influence of serum prolactin levels on disease severity in patients with chronic plaque-type psoriasisFootnoteFootnote

&
Pages 385-389 | Received 24 Mar 2013, Accepted 11 Apr 2013, Published online: 17 May 2019

References

  • P.van de KerkhofSchalkwijk J.PsoriasisJ.BologniaJ.JorrizoR.RapiniDermatology2nd ed.2008ElsevierMosby pp. 115–135
  • F.O.NestleD.H.KaplanJ.BarkerPsoriasisN Engl J Med3612009496509
  • G.KruegerC.N.EllisPsoriasis – recent advances in understanding its pathogenesis and treatmentJ Am Acad Dermatol532005S94100
  • B.A.WeiglThe significance of stress hormones (glucocorticoids, catecholamines) for eruptions and spontaneous remission phases in psoriasisInt J Dermatol392000678688
  • J.E.MuraseK.K.ChanT.J.GariteD.M.CooperG.D.WeinsteinHormonal effect on psoriasis in pregnancy and post partumArch Dermatol1412005601606
  • P.C.ArckA.SlominskiT.C.TheoharidesE.M.PetersR.PausNeuroimmunology of stress: skin takes center stageJ Invest Dermatol126200616971704
  • K.FoitzikE.A.LanganR.PausProlactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormoneJ Invest Dermatol129200910711087
  • D.DeleuM.G.NorthwayY.HanssensAn evidence-based review of dopamine receptor agonists in the treatment of Parkinson’s diseaseSaudi Med J23200211651175
  • S.E.WalkerBromocriptine treatment of systemic lupus erythematosusLupus102001762768
  • G.WeberM.NeidhardtH.FreyK.GalleA.GeigerTreatment of psoriasis with bromocriptinArch Dermatol Res2711981437439
  • M.Sanchez ReganaP.Umbert MilletPsoriasis in association with prolactinoma: three casesBr J Dermatol1432000864867
  • G.WeberH.FreyTreatment of psoriasis arthropathica with bromocriptineZ Hautkr6120198614561466
  • R.W.McMurrayBromocriptine in rheumatic and autoimmune diseasesSemin Arthritis Rheum3120012132
  • M.E.MolitchPathologic hyperprolactinemiaEndocrinol Metab Clin North Am211992877901
  • D.L.TorreA.FalorniPharmacological causes of hyperprolactinemiaTher Clin Risk Manag32007929951
  • T.FredrikssonU.PetterssonSevere psoriasis – oral therapy with a new retinoidDermatologica1571978238244
  • A.S.GiasuddinA.I.El-SherifS.I.El-OjaliProlactin: does it have a role in the pathogenesis of psoriasis?Dermatology1971998119122
  • E.Dilme-CarrerasG.Martin-EzquerraM.Sanchez-ReganaP.Umbert-MilletSerum prolactin levels in psoriasis and correlation with cutaneous disease activityClin Exp Dermatol3620112932
  • C.GorpeliogluE.GungorN.AlliIs prolactin involved in etiopathogenesis of psoriasis?J Eur Acad Dermatol Venereol22200811351136
  • E.A.El-KhateebN.M.Zuel-FakkarS.M.EidS.E.Abdul-WahabProlactin level is significantly elevated in lesional skin of patients with psoriasisInt J Dermatol502011693696
  • K.MorkawaF.OsekoS.MorikawaImmunosuppressive property of bromocriptine on human B lymphocyte function in vitroClin Exp Immunol931993200205
  • K.MorikawaF.OsekoS.MorikawaImmunosuppressive activity of bromocriptine on human T lymphocyte function in vitroClin Exp Immunol951994514518
  • J.J.GuilhouE.GuilhouBromocriptine treatment of psoriasisArch Dermatol Res2731982159160
  • F.EulryB.BauduceauH.MayaudonD.LechevalierM.DucorpsJ.MagninTherapeutic efficacy of bromocriptine in psoriatic arthritis (two case-reports)Rev Rhum Engl Ed621995607608
  • D.BuskilaS.SukenikG.HolcbergJ.HorowitzImprovement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemiaJ Rheumatol181991611612